世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

遺伝子治療の世界市場の機会と2032年までの戦略Including:1) 遺伝子治療のタイプ別生殖細胞療法;体細胞療法2) ベクター別:ベクター別:ウイルスベクター、非ウイルスベクター3)エンドユーザー別:バイオ製薬企業、研究機関バイオ製薬企業;研究機関4) 用途別オンコロジー;希少疾患;変形性膝関節症;神経疾患Covering:ノバルティスAG、F.ホフマン・ラ・ロシュLtd、ギリアド・サイエンシズInc、アステラス製薬Inc、バイオジェンInc


Gene Therapy Global Market Opportunities And Strategies To 2032Including: 1) By Gene Therapy Type: Germline Therapy; Somatic Cell Therapy2) By Vector: Viral Vector; Non-Viral Vector3) By End Users: Biopharmaceutical Companies; Research Institutes4) By Application: Oncology; Orphan Disease; Knee Osteoarthritis; Neurological DisordersCovering: Novartis AG; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; Astellas Pharma Inc; Biogen Inc

The Business Research Company社の『Gene Therapy Global Market Opportunities And Strategies To 2032』は、戦略家、マーケティング担当者、上級管理職が、COVID-19閉鎖から脱却した世界の遺伝子治療市場を評... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Business Research Company (TBRC)
ザ・ビジネスリサーチカンパニー
2023年4月25日 US$5,000
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
305 英語

 

サマリー

The Business Research Company社の『Gene Therapy Global Market Opportunities And Strategies To 2032』は、戦略家、マーケティング担当者、上級管理職が、COVID-19閉鎖から脱却した世界の遺伝子治療市場を評価するために必要な重要情報を提供しています。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスからどのような影響を受けているのか、またウイルスの影響が和らぐにつれて市場がどのように立ち上がり、成長していくのかを理解することができます。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。


説明
遺伝子治療の最大かつ最速の成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?ビジネスリサーチ社の遺伝子治療市場グローバルレポートは、これらすべての質問とその他多くの質問に回答します。
当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略などを取り上げています。地域別に市場の過去および予測成長を追跡しています。また、同市場をより広範な遺伝子治療市場の文脈に位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています。
- 序論と市場の特徴
遺伝子治療市場に関する定義や解説、市場の対象となるセグメントについて簡単に紹介しています。
- 主要動向
世界の遺伝子治療市場を形成している主要トレンドにハイライトを当てています。また、同市場における今後の展開についても取り上げます。
- 世界市場の種類と成長
世界の過去(2017年~2022年)、予測(2022年~2027年)、(2027年~2032年)市場価値、過去および予測期間における市場の成長を支え、制御する推進要因と阻害要因。
- 地域別分析
地域別の過去(2017-2022年)および予測(2022-2027年)、(2027-2032年)市場価値と成長率、市場シェア比較。
- 市場セグメンテーション
市場における遺伝子治療タイプ別、ベクター別、用途別、エンドユーザー別の市場価値(2017-2032年)と各セグメント別の分析を収録。
- 地域別市場規模と成長
地域別の市場規模(2022年)、過去(2017年~2022年)と予測(2022年~2027年)、(2027年~2032年)の市場価値、地域内の国々の成長と市場シェア比較。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。
- 競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
- 主要なM&A
本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。
- 市場機会と戦略
調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報を交えて記述しています。
- 結論と提言
製品・サービスの提供地域、マーケティング戦略、ターゲット層などの観点から、遺伝子治療プロバイダーへの提言を含む。
- 付録
このセクションには、本レポートで使用されているNAICSコード、略語、通貨コードの詳細が含まれています。

対象範囲
対象市場
1) 遺伝子治療タイプ別生殖細胞療法;体細胞療法
2) ベクター別ウイルスベクター;非ウイルスベクター
3) エンドユーザー別バイオ製薬企業、研究機関、その他エンドユーザー
4) アプリケーション別癌、希少疾患、変形性膝関節症、神経疾患

言及された企業ノバルティス;F.ホフマン・ラ・ロシュ;ギリアド・サイエンシズ;アステラス製薬;バイオジェン

国名オーストラリア、中国、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列:過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、遺伝子治療指標の比較。

データ区分:国別および地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。


当レポートでは、遺伝子治療市場について説明し、歴史的期間と呼ばれる2017-2022年と予測期間と呼ばれる2022-2027年をカバーし、さらに2027-2032年の予測も行っています。本レポートでは、各地域および各地域内の主要経済圏における市場を評価しています。

世界の遺伝子治療市場は、2017年以降15.8%の複合年間成長率(CAGR)で増加し、2022年には約73億7,080万ドルの規模に達した。同市場は、2022年の73億7,080万ドルから2027年には240億2,710万ドルへと26.7%の成長率が見込まれている。その後、2027年からCAGR13.4%で成長し、2032年には450億7,190万ドルに達すると予想される。

歴史的期間の成長は、医薬品研究開発費の増加、官民パートナーシップの増加、政府投資、脊髄性筋萎縮症患者の増加によってもたらされた。過去期間の成長にマイナスの影響を与えた要因は、標的外特異性、細胞へのヌクレオチド送達における課題、ヌクレオチドの不安定性、規制変更による課題、医療アクセスの低さ、償還の課題、コロナウイルスの流行であった。

今後、がん患者の増加、高齢化人口の増加、製薬部門における研究開発費の増加、遺伝子治療への注目の高まりが市場を牽引していくだろう。今後の遺伝子治療市場の成長を阻害する要因としては、遺伝子治療の高コスト、厳しい規制、ロシア・ウクライナ戦争などが挙げられる。

遺伝子治療市場は、ベクターによってウイルスベクターと非ウイルスベクターに区分される。ウイルスベクターは、遺伝子治療市場においてベクター別で最大のセグメントであり、2022年には65億5,570万ドル、市場全体の88.9%を占める。年平均成長率(CAGR)は26.7%で、今後最も急成長するセグメントと予想される。

遺伝子治療市場は、用途別に腫瘍、希少疾患、変形性膝関節症、神経疾患に区分される。がん市場は、遺伝子治療市場の用途別で最大のセグメントであり、2022年には市場全体の44.2%にあたる32億5,820万ドルを占める。神経疾患市場は、CAGR 27.7%で今後最も急成長するセグメントと予想される。

遺伝子治療市場は、エンドユーザー別にバイオ製薬企業、研究機関、その他のエンドユーザーに区分される。遺伝子治療市場のエンドユーザー別ではバイオ製薬企業が最大セグメントで、2022年には38億8,270万ドル、市場全体の52.7%を占める。その他のエンドユーザー市場は、CAGR 27.6%で今後最も急成長するセグメントと予想される。

遺伝子治療市場は、遺伝子治療の種類によって生殖細胞治療と体細胞治療に区分される。体細胞療法は遺伝子治療の種類別で最大のセグメントであり、2022年の市場全体の95.0%にあたる70億220万ドルを占めた。年平均成長率(CAGR)は26.7%で、今後最も急成長が見込まれる分野である。

遺伝子治療市場で最大の地域は北米で、2022年の世界市場の44.6%を占めた。次いで西ヨーロッパ、アジア太平洋、その他の地域と続く。今後、遺伝子治療市場で最も急速に成長する地域は南米と中東で、2022〜2027年のCAGRはそれぞれ44.4%と42.3%である。

世界の遺伝子治療市場は集中しており、大手企業は少数である。同市場における競合企業上位10社は、2021年には市場全体の53.81%を占めている。ノバルティスAGが市場シェア14.57%で最大、次いでF.ホフマン・ラ・ロシュ7.99%、ギリアド・サイエンシズ7.55%、アステラス製薬6.11%、バイオジェン3.81%、ユニキュアNV3.64%、REGENXBIO Inc.3.26%、ブリストル・マイヤーズスクイブ2.84%、バイオマリン・ファーマシューティカルズ2.33%、ジャズ・ファーマシューティカルズ1.71%となっている。

ベクター別の遺伝子治療市場で最大のビジネスチャンスはウイルスベクター市場にあり、2027年までに世界の年間売上高148億6,890万ドルに達するだろう。遺伝子治療市場のアプリケーション別では、2027年までに世界の年間売上高が70億8,000万ドルに達するオンコロジー市場に最大のビジネスチャンスが生まれるだろう。遺伝子治療市場のエンドユーザー別機会上位はバイオ製薬会社市場で、2027年までに88億8300万ドルの世界年間売上高を獲得する。遺伝子治療別の遺伝子治療市場における最大のビジネスチャンスは体細胞治療市場にあり、2027年までに158億3,960万ドルの世界年間売上高を獲得する。遺伝子治療の市場規模が最も拡大するのは米国で、46億1,200万ドルである。

遺伝子治療市場の市場トレンドに基づく戦略には、投資と製造施設の拡大、テトラサイクリン対応自己サイレンシングアデノウイルス(TESSA)技術の使用、細胞・遺伝子治療プラットフォームの立ち上げ、パートナーシップと共同研究、遺伝子編集への注目の高まり、戦略的M&Aなどがある。

遺伝子治療業界で採用されている戦略には、規制当局の承認取得による事業活動の強化、戦略的提携やパートナーシップによる事業活動の強化、戦略的買収による事業能力の拡大、事業拡大による事業能力の強化などがある。

ビジネス・リサーチ・カンパニーは、この機会を活用するため、遺伝子治療企業に対し、製造施設拡張への投資に注力すること、テトラサイクリン対応自己サイレンシングアデノウイルス(TESSA)技術の利用に注力すること、遺伝子編集への注力を高めること、新興市場での拡大を図ること、先進国市場への注力を継続すること、提携・協力に注力すること、M&Aに注力すること、競争力のある価格の製品を提供すること、展示会やイベントに参加すること、B2Bプロモーションを利用し続けること、急成長するエンドユーザーをターゲットにし続けること、急成長するアプリケーションに注力することを推奨している。

ページTOPに戻る


目次

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Gene Therapy Market Definition And Segmentations
6.4. Market Segmentation By Gene Therapy Type
6.4.1. Germline Therapy
6.4.2. Somatic Cell Therapy
6.5. Market Segmentation By Vector
6.5.1. Viral Vector
6.5.2. Non-Viral Vector
6.6. Market Segmentation By End Users
6.6.1. Biopharmaceutical Companies
6.6.2. Research Institutes
6.6.3. Other End Users
6.7. Market Segmentation By Application
6.7.1. Oncology
6.7.2. Orphan Disease
6.7.3. Knee Osteoarthritis
6.7.4. Neurological Disorders
7. Major Market Trends
7.1. Growing Investments and Manufacturing Facility Expansion
7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology
7.3. Launch Of Cell And Gene Therapy Platforms
7.4. Partnerships And Collaborations
7.5. Rising Focus On Gene Editing
7.6. Strategic Mergers And Acquisitions
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Gene Therapy Market Segmentation
9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Gene Therapy Market, Regional and Country Analysis
10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Gene Therapy Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. South Korea Market
11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Gene Therapy Market: Country Analysis
12.9. UK Market
12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Gene Therapy Market: Country Analysis
13.9. Russia Market
13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Gene Therapy Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Gene Therapy Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
18.1. Company Profiles
18.2. Novartis AG
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. F. Hoffmann-La Roche AG
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Gilead Sciences Inc.
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Financial Overview
18.5. Astellas Pharma Inc.
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Biogen Inc.
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers And Acquisitions
19.1. Rocket Pharmaceuticals Acquired Renovacor
19.2. Eli Lilly Acquired Akouos
19.3. Ginkgo Bioworks Acquired Altar and Circularis
19.4. Solvias Acquired Cergentis
19.5. Novartis Acquired Gyroscope Therapeutics
19.6. FHI Clinical Acquired Triclinium Clinical Development
19.7. WuXi AppTec Acquired OXGENE
20. Pipeline Analysis
20.1. Products In Development
20.2. Approved Products
21. Opportunities And Strategies
21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Gene Therapy Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Gene Therapy Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

 

ページTOPに戻る


 

Summary

Gene Therapy Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gene therapy market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis


Description:
Where is the largest and fastest growing market for gene therapy? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The gene therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider gene therapy market; and compares it with other markets.

The report covers the following chapters
• Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the gene therapy market.
• Key Trends
Highlights the major trends shaping the global gene therapy market. This section also highlights likely future developments in the market.
• Global Market Type and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
• Market Segmentation
Contains the market values (2017-2032) and analysis for each segment by gene therapy type, by vector, by application and by end users in the market.
• Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations
This section Includes recommendations for gene therapy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope
Markets Covered:
1) By Gene Therapy Type: Germline Therapy; Somatic Cell Therapy
2) By Vector: Viral Vector; Non-Viral Vector
3) By End Users: Biopharmaceutical Companies; Research Institutes; Other End Users
4) By Application: Oncology; Orphan Disease; Knee Osteoarthritis; Neurological Disorders

Companies Mentioned: Novartis AG; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; Astellas Pharma Inc; Biogen Inc

Countries: Australia, China, India, Indonesia, Japan, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; gene therapy indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This report describes and explains the gene therapy market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global gene therapy market reached a value of nearly $7,370.8 million in 2022, having increased at a compound annual growth rate (CAGR) of 15.8% since 2017. The market is expected to grow from $7,370.8 million in 2022 to $24,027.1 million in 2027 at a rate of 26.7%. The market is then expected to grow at a CAGR of 13.4% from 2027 and reach $45,071.9 million in 2032.

Growth in the historic period resulted from rising pharmaceutical R&D expenditure, a rise in public-private partnerships, government investments and rising cases of spinal muscular atrophy. Factors that negatively affected growth in the historic period were off-target specificity, challenges in nucleotide delivery to cells, instability of the nucleotides, challenges due to regulatory changes, low healthcare access, reimbursement challenges and the coronavirus pandemic.

Going forward, an increasing number of cancer cases, a growing aging population, increasing research and development spending in the pharmaceutical sector and a rising focus on gene therapy will drive the market. Factors that could hinder the growth of the gene therapy market in the future include high cost of gene therapy, stringent regulations and the Russia- Ukraine war.

The gene therapy market is segmented by vector into viral vector and non-viral vector. The viral vector was the largest segment of the gene therapy market by vector, accounting for $6,555.7 million or 88.9% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 26.7%.

The gene therapy market is segmented by application into oncology, orphan disease, knee osteoarthritis and neurological disorders. The oncology market was the largest segment of the gene therapy market by application, accounting for $3,258.2 million or 44.2% of the total market in 2022. The neurological disorders market is expected to be the fastest-growing segment going forward at a CAGR of 27.7%.

The gene therapy market is segmented by end users into biopharmaceutical companies, research institutes and other end users. The biopharmaceutical companies was the largest segment of the gene therapy market by end users, accounting for $3,882.7 million or 52.7% of the total market in 2022. The other end users market is expected to be the fastest-growing segment going forward at a CAGR of 27.6%.

The gene therapy market is segmented by gene therapy type into germline therapy and somatic cell therapy. The somatic cell therapy was the largest segment of the gene therapy market by gene therapy type, accounting for $7,002.2 million or 95.0% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 26.7%.

North America was the largest region in the gene therapy market, accounting for 44.6% of the global market in 2022. It was followed by Western Europe, Asia Pacific and the other regions. Going forward, the fastest growing regions in the gene therapy market will be South America and the Middle East, where growth will be at CAGRs of 44.4% and 42.3% respectively from 2022-2027.

The global gene therapy market is concentrated, with a few large players. The top ten competitors in the market made up to 53.81% of the total market in 2021. Novartis AG was the largest competitor with 14.57% share of the market, followed by F. Hoffmann-La Roche Ltd with 7.99%, Gilead Sciences Inc. with 7.55%, Astellas Pharma Inc. with 6.11%, Biogen Inc. with 3.81%, UniQure NV with 3.64%, REGENXBIO Inc. with 3.26%, Bristol-Myers Squibb with 2.84%, BioMarin Pharmaceuticals Inc. with 2.33% and Jazz Pharmaceuticals Inc. with 1.71%.

The top opportunities in the gene therapy market by vector will arise in the viral vector market, which will gain $14,868.9 million of global annual sales by 2027. The top opportunities in the gene therapy market by application will arise in the oncology market, which will gain $7,080.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by end users will arise in the biopharmaceutical companies market, which will gain $8,883.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by gene therapy will arise in the somatic cell therapy market, which will gain $15,839.6 million of global annual sales by 2027. The gene therapy market size will gain the most in the USA at $4,612.0 million.

Market-trend-based strategies for the gene therapy market include growing investments and manufacturing facility expansion, use of tetracycline-enabled self-silencing adenovirus (TESSA) technology, launch of cell and gene therapy platforms, partnerships and collaborations, rising focus on gene editing and strategic mergers and acquisitions.

Player-adopted strategies in the gene therapy industry include enhancing business operations through securing regulatory approvals, strengthening business activities through strategic collaborations and partnerships, expanding business capabilities through strategic acquisitions and strengthening operational capabilities through business expansions.

To take advantage of the opportunities, The Business Research Company recommends the gene therapy companies to focus on investments in manufacturing facility expansion, focus on use of tetracycline-enabled self-silencing adenovirus (TESSA) technology, increase focus on gene editing, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, focus on mergers and acquisitions, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing end-users, and focus on fast-growing applications.



ページTOPに戻る


Table of Contents

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Gene Therapy Market Definition And Segmentations
6.4. Market Segmentation By Gene Therapy Type
6.4.1. Germline Therapy
6.4.2. Somatic Cell Therapy
6.5. Market Segmentation By Vector
6.5.1. Viral Vector
6.5.2. Non-Viral Vector
6.6. Market Segmentation By End Users
6.6.1. Biopharmaceutical Companies
6.6.2. Research Institutes
6.6.3. Other End Users
6.7. Market Segmentation By Application
6.7.1. Oncology
6.7.2. Orphan Disease
6.7.3. Knee Osteoarthritis
6.7.4. Neurological Disorders
7. Major Market Trends
7.1. Growing Investments and Manufacturing Facility Expansion
7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology
7.3. Launch Of Cell And Gene Therapy Platforms
7.4. Partnerships And Collaborations
7.5. Rising Focus On Gene Editing
7.6. Strategic Mergers And Acquisitions
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Gene Therapy Market Segmentation
9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Gene Therapy Market, Regional and Country Analysis
10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Gene Therapy Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. South Korea Market
11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Gene Therapy Market: Country Analysis
12.9. UK Market
12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Gene Therapy Market: Country Analysis
13.9. Russia Market
13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Gene Therapy Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Gene Therapy Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
18.1. Company Profiles
18.2. Novartis AG
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. F. Hoffmann-La Roche AG
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Gilead Sciences Inc.
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Financial Overview
18.5. Astellas Pharma Inc.
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Biogen Inc.
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers And Acquisitions
19.1. Rocket Pharmaceuticals Acquired Renovacor
19.2. Eli Lilly Acquired Akouos
19.3. Ginkgo Bioworks Acquired Altar and Circularis
19.4. Solvias Acquired Cergentis
19.5. Novartis Acquired Gyroscope Therapeutics
19.6. FHI Clinical Acquired Triclinium Clinical Development
19.7. WuXi AppTec Acquired OXGENE
20. Pipeline Analysis
20.1. Products In Development
20.2. Approved Products
21. Opportunities And Strategies
21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Gene Therapy Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Gene Therapy Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

The Business Research Company (TBRC)社の医薬分野での最新刊レポート

本レポートと同じKEY WORD(gene)の最新刊レポート


よくあるご質問


The Business Research Company (TBRC)社はどのような調査会社ですか?


The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る